TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    The Motley Fool
    Investing

    4 Easy Ways to Invest in This Upcoming $1.2 Trillion Opportunity

    There's a common theme of why now's a good time to buy Loblaw Companies Limited (TSX:L), Extenticare Inc. (TSX:EXE), Chartwell…

    Read more »

    Investing

    (Review) These Stocks Have Hit 52-Week Highs: Should You Buy, Sell, or Hold?

    CGI Group Inc. (TSX:GIB.A)(NYSE:GIB) and Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) have both hit 52-week highs. Here’s what to consider.

    Read more »

    Investing

    Will Pfizer Inc. Look to Buy Valeant Pharmaceuticals Intl Inc.?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is the right size for Pfizer Inc. (NYSE:PFE), but Valeant might actually turn out to…

    Read more »

    Investing

    Invest in China With Valeant Pharmaceutical Intl Inc.

    China's middle class is growing, expanding the market for Valeant Pharmaceuticals International Inc.'s (TSX:VRX)(NYSE:VRX) products.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceutical International Inc. Changes Strategy; Is Now the Time to Buy?

    Valeant Pharmaceutical International Inc. (TSX:VRX)(NYSE:VRX) is changing strategies and avoiding acquisition. Does that make it a buy?

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceutical International Inc. Lost its Bid for Allergan, Inc; Now What?

    Valeant Pharmaceutical International Inc. (TSX:VRX)(NYSE:VRX) failed to buy Allergan, Inc. (NYSE:AGN), but I still think it is worth adding to…

    Read more »

    The Motley Fool
    Investing

    Should You Follow Billionaire Bill Ackman and Bet on Valeant Pharmaceuticals International Inc.?

    Valeant Pharmaceuticals International Inc. (TSX:VRX)(NYSE:VRX) has achieved fantastic returns thus far. Will this continue?

    Read more »

    The Motley Fool
    Investing

    The Argument For and Against Valeant Pharmaceutical International Inc.’s Growth Strategy

    Valeant Pharmaceuticals International Inc. (TSX:VRX)(NYSE:VRX) invests little money in R&D and a lot in acquisitions. Is that good?

    Read more »

    The Motley Fool
    Investing

    Making Sense of the Valeant Pharmaceuticals International Inc. and Allergan, Inc. Acquisition Talks

    There's a big mess going on between Valeant Pharmaceuticals International Inc. (TSX:VRX)(NYSE:VRX) and Allergan, Inc. (NYSE:AGN). Dig deeper and you…

    Read more »

    The Motley Fool
    Investing

    3 Growth Stocks I’d Buy With a $55,000 Inheritance

    Here's why Constellation Software Inc. (TSX:CSU), Valeant Pharmaceuticals International Inc. (TSX:VRX)(NYSE:VRX), and Canadian National Railway Company (TSX:CNR)(NYSE:CNI) are great investment…

    Read more »

    The Motley Fool
    Investing

    Why Valeant Pharmaceuticals Intl Inc. and Allergan Inc. Would Be Better Together

    A combined Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) and Allergan Inc. (NYSE:AGN) would outperform the standalone units.

    Read more »

    The Motley Fool
    Investing

    Three Stocks for Your Long-Term Growth Portfolio

    Consider BlackBerry Ltd. (TSX:BB)(NASDAQ:BBRY), Cameco Corporation (TSX:CCO)(NYSE:CCJ), and Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) for a portfolio that will flourish in…

    Read more »